Brigham study shows Sanofi diabetes drug safe for heart

Researchers from a Boston hospital detailed the results of a five-year study, showing that a Sanofi drug which helps moderate glucose levels in those with type II diabetes, did not increase the risk of a cardiovascular event. Marc Pfeffer, Victor J. Dzau Professor of Medicine at Brigham and Women's Hospital, is principal investigator of the study.

Read the full article